These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6935447)

  • 21. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroepidemiology of human sarcoma antigen (S1).
    Hirshaut Y; Pei DT; Marcove RC; Mukherji B; Spielvogel AR; Essner E
    N Engl J Med; 1974 Nov; 291(21):1103-7. PubMed ID: 4608025
    [No Abstract]   [Full Text] [Related]  

  • 23. [Detection of the antibody against tumor cell surface antigen].
    Ueda R
    Nihon Rinsho; 1979 Jun; Suppl():1591-4. PubMed ID: 90745
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunophenotyping in leukaemias is not a luxury.
    Kurukulasuriya AP; Wijesiriwardene B; Perera TK
    Ceylon Med J; 1998 Jun; 43(2):117-8. PubMed ID: 9704557
    [No Abstract]   [Full Text] [Related]  

  • 25. Human normal and leukemia cell surface antigens. Mouse monoclonal antibodies as probes.
    Levy R; Dilley J; Lampson LA
    Curr Top Microbiol Immunol; 1978; 81():164-9. PubMed ID: 567556
    [No Abstract]   [Full Text] [Related]  

  • 26. Current trends in childhood acute lymphocytic leukemia and non-hodgkin's lymphoma.
    Castleberry RP
    Ala J Med Sci; 1981 Jul; 18(3):243-8. PubMed ID: 6945058
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological classification of acute lymphatic leukemia.
    Chen PM; Ho CK
    Haematol Blood Transfus; 1983; 28():124-5. PubMed ID: 6574948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies of adult T-cell leukemia].
    Takatsuki K; Yamaguchi K; Kawano F; Nishimura H; Tsuda H; Sanada I; Fujiwara K
    Nihon Rinsho; 1983 Nov; 41(11):2659-72. PubMed ID: 6608607
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between different cell surface markers in chronic lymphocytic leukemia.
    Potomski J; Harłozińska A; Becker M; Noworolska A
    Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous occurrence of chronic granulocytic leukemia and chronic lymphoid leukemia.
    Leoni F; Ferrini PR; Castoldi GL; Pata M; Del Prete GF; Tomasi P
    Haematologica; 1987; 72(3):253-6. PubMed ID: 3114094
    [No Abstract]   [Full Text] [Related]  

  • 32. [Flow cytometric analysis of common ALL antigen and DNA content of leukemic marrow blasts in children with ALL].
    Tsurusawa M; Katano N; Yamamoto Y; Kawai S; Fujimoto T; Naruse M
    Rinsho Ketsueki; 1986 May; 27(5):738-46. PubMed ID: 2943911
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunologic heterogeneity of acute lymphoblastic leukemia in children detected with xenogeneic antisera].
    Baryshnikov AIu; Tupitsin NN; Morozova LF; Tumian BG; Kadagidze ZG
    Ter Arkh; 1983; 55(11):81-6. PubMed ID: 6581572
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological classification of adult lymphocytic leukemia based on the conventional cell markers and monoclonal antibody-defined cell surface antigens.
    Kawashima K; Nagura E; Ogura M; Murase T; Morishita Y; Ohno R; Kato Y; Yokomaku S; Mizuno S; Takeyama H
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1017-29. PubMed ID: 3864322
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies of adult T-cell leukemia. Part II. Anti-ATLA antibody in the families of ATL patients].
    Fujishita M
    Rinsho Ketsueki; 1983 May; 24(5):533-9. PubMed ID: 6604174
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia.
    Greaves MF; Lister TA
    N Engl J Med; 1981 Jan; 304(2):119-20. PubMed ID: 6934374
    [No Abstract]   [Full Text] [Related]  

  • 37. [Surface marker analysis of lymphoid malignancy].
    Takiguchi T; Konda S
    Rinsho Byori; 1984 Sep; 32(9):946-53. PubMed ID: 6394824
    [No Abstract]   [Full Text] [Related]  

  • 38. Alterations of HLe-1 (T200) fluorescence intensity on acute lymphoblastic leukemia cells may relate to therapeutic outcome.
    Caldwell CW; Patterson WP; Hakami N
    Leuk Res; 1987; 11(1):103-6. PubMed ID: 3543510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Common null antigen of acute lymphoblastic leukemia and "lymphoid" variant of the blastic phase of chronic myeloid leukemia].
    Baryshnikov AIu; Morozova LF; Volkova MA; Frinovskaia IV; Maiakova SA
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):23-5. PubMed ID: 6757918
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-A and anti-B isohemagglutinins in the course of children's leukemias.
    Kubíková-Kourilová A; Zahálková M
    Neoplasma; 1978; 25(4):439-44. PubMed ID: 278909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.